Company Profile
Zhejiang Starry Pharmaceutical researches, develops, produces, and sells pharmaceutical raw materials in China and globally. Its business is organized into Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadobenate dimeglumine injections.
Its portfolio also includes contrast agent APIs and intermediates consisting of iohexol, iopamidol, iodixanol, ioversol, iopromide, iomeprol, gadobenate dimeglumine, gadobutrol, and products, quinolone APIs and intermediates, such as levofloxacin and levofloxacin hydrochloride, and CMO/CDMO APIs and intermediates
Including CIBA, OPAA, 3N, ILC, JSQ, iodine, aza, and loxoprofen sodium, as well as technology promotion and application. Its portfolio also includes investment, physical education, and wholesale activities. Zhejiang Starry Pharmaceutical Co.,Ltd. was incorporated in 1997 and is headquartered in Taizhou, China.